SCHEMBL845567

SCHEMBL845567

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3Oc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1ccccc1Oc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
HTT P42858 1/20 0.50
PABPC1 P11940 1/20 0.50
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HCRTR1 O43613 3/20 0.47
HCRTR2 O43614 3/20 0.47
CFD P00746 2/20 0.47
NPSR1 Q6W5P4 3/20 0.46
GAA P10253 1/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
EP300 Q09472 1/20 0.45
CREBBP Q92793 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL871785 0.92 HCRTR1 (0.43) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL845618 0.89 MAPK1 (0.56) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL13272387 0.89 HCRTR1 (0.42) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL845353 0.88 KDM4E (0.52) ALDH1A1MAPK1PABPC1CYP2C9CYP2C19
SCHEMBL845305 0.88 GAA (0.58) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL845279 0.87 ALDH1A1 (0.53) ALDH1A1MAPK1HTTCYP2C9CYP2C19
SCHEMBL845473 0.86 HSD17B10 (0.47) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL13272499 0.84 HCRTR1 (0.39) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL845289 0.84 ALDH1A1 (0.48) ALDH1A1MAPK1HTTPABPC1CYP2C9
SCHEMBL845226 0.84 ALDH1A1 (0.56) ALDH1A1MAPK1HTTPABPC1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed